Future directions in thrombolysis for myocardial infarction: what are the unanswered questions?
Lefkovits
J
J
Department of Cardiology, Cleveland Clinic Foundation, Ohio 44195.
Topol
E J
EJ
D000818:Animals; D002986:Clinical Trials as Topic; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000503:physiopathology; D016032:Randomized Controlled Trials as Topic; D013300:Streptokinase / Q000627:therapeutic use; D015912:Thrombolytic Therapy / Q000379:methods / Q000639:trends; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use; D014654:Vascular Patency
D013300:Streptokinase; D010959:Tissue Plasminogen Activator